On February 2, 2023, Global Pharma Healthcare recalled the EzriCare Eye Drop and Delsam Pharma Eye Drop products due to bacterial contamination. Across several states, people have suffered serious injuries due to the application of the artificial tear lubricant. There have been cases of permanent vision loss, surgical intervention, and fatalities.
Since the voluntary recall, several separate lawsuits have been filed against Global Pharma Healthcare. At this time, these lawsuits are still being addressed separately and have not been brought together in a multidistrict litigation. There is a possibility that these separate lawsuits could become a mass tort action.
If you have used these products and have suffered injuries, you may be qualified to file a personal injury lawsuit as well.
For a free legal consultation with a pharma eye lawsuits lawyer serving Nationwide, call (725) 900-9000
What Are EzriCare and Delsam Pharma Eye Drops?
EzriCare and Delsam Pharma Eye Drops were readily available products used to alleviate dry eyes, often found at popular retailers like Walmart and Amazon. Dry eyes are a common issue caused by insufficient tear production. These products provided relief through the application of an artificial tear lubricant. These artificial tears have been the subject of legal action, though, with both Walmart and Amazon potentially being involved.
The key ingredient in EzriCare and Delsam Pharma Eye Drops is carboxymethylcellulose sodium, which acts as a lubricant to relieve dry eye symptoms. This ingredient is commonly used in other over-the-counter eye drops for the same purpose.
Carboxymethylcellulose Sodium Can Effectively Relieve Eyes
The efficacy of these drops is notable. The lubricating properties of carboxymethylcellulose sodium help soothe the eyes and create a protective barrier against further irritation. This product can effectively reduce symptoms like itching, burning, and stinging, leading to an overall improvement in eye comfort.
Previously, EzriCare and Delsam Pharma Eye Drops were considered safe and widely trusted. However, recent events have raised concerns and prompted a reassessment of their usage.
Nationwide Pharma Eye Lawsuits Lawyer Near Me (725) 900-9000
EzriCare and Delsam Pharma’s Recall for Pseudomonas Aeruginosa
On January 20, 2023, the CDA shared findings from an investigation regarding a series of infections resistant to antibiotics that were connected to the usage of EzriCare and Delsam Pharma Artificial Tears.
The CDC has identified reported cases of Pseudomonas aeruginosa bacterial infections in various states, including California, Florida, New York, Texas, Colorado, Connecticut, New Jersey, New Mexico, Nevada, Utah, Illinois, North Carolina, Pennsylvania, South Dakota, Wisconsin, Delaware, Ohio, and Washington.
Instances of patients developing eye infections and requiring medical attention were reported. Other victims reported suffering from respiratory and urinary tract infections. Unfortunately, even with medical care, four people have lost their lives, and 14 individuals have experienced a loss of vision.
Click to contact our Mass Torts Lawyers today
What Is Pseudomonas Aeruginosa?
Pseudomonas aeruginosa is a hazardous strain of bacteria that is frequently present in soil, water, and various other surroundings. This type of bacteria flourishes in watery environments, making the eyes particularly susceptible to its attack.
This bacterium can survive and thrive not only in typical atmospheric conditions but also in low-oxygen environments, allowing it to inhabit both natural and artificial settings. Its adaptability poses a significant threat, as it can colonize and infect compromised human tissue or individuals with weakened immune systems.
Pseudomonas aeruginosa possesses a distinctive ability to create biofilms, which are communities of drug-resistant bacteria that adhere to surfaces and form a protective matrix consisting of polysaccharides, proteins, and extracellular DNA. This quality enables the bacteria to elude the host’s immune system and withstand the effects of antibiotics.
Pseudomonas Aeruginosa Is Highly Resistant to Medical Treatment
What is concerning about a Pseudomonas aeruginosa infection is its resistance to multiple drugs, making it challenging for doctors to effectively treat infections caused by these dangerous bacteria.
Pseudomonas aeruginosa employs various alarming mechanisms to develop resistance against antibiotics, including the production of enzymes that neutralize the drugs, the active pumping of drugs out of the cell, and the alteration of the drug’s target site, rendering it ineffective.
Complete a Free Case Evaluation form now
EzirCare & Delsam Pharma Eye Drops Timeline
June 5, 2023:
There have been 14 lawsuits filed in federal courts by individuals who have suffered injuries resulting from the use of bacterial-contaminated EzriCare Eye Drops and Delsam Pharma Eye Drops. These cases are currently pending in 7 different federal districts.
May 23, 2023:
The CDC has reported a total of 81 registered cases of infections in 18 states caused by the recalled artificial tears products. The outbreak has been associated with four deaths resulting from severe infections. In four other instances, patients required eye removal surgery.
April 8, 2023:
The FDA safety investigators released a report presenting unfavorable evidence against the defendants in the eye drops lawsuit.
March 22, 2023:
Another lawsuit related to artificial tears was filed in Florida by a man who experienced vision loss in one eye.
February 14, 2023:
The first civil lawsuit, a class action asserting consumer fraud claims related to the sale of contaminated EzriCare and Delsam Pharma Artificial Tears eye drops, was filed in federal court on February 14, 2023.
February 7, 2023:
Global Pharma, the Indian company manufacturing EzriCare and Delsam Pharma Artificial Tears eye drops, announces a nationwide recall of all EzriCare and Delsam Pharma eye drops in the U.S.
February 2, 2023:
From a U.S. Food & Drug Administration (FDA) report, Global Pharma Healthcare issued a public statement acknowledging contact with FDA and CDC officials regarding potential eye drop contamination. The statement assured that Global Pharma Healthcare had taken action to halt further distribution or sale of the affected eye drops.
Why Choose Van Law Firm for Your EzriCare & Delsam Pharma Eye Drop Contamination Lawsuit
Navigating the complexities of the legal process, especially when dealing with an injury, can be challenging. At Van Law, our personal injury lawyers understand the difficulties you face during this time. We empathize with your situation and can ensure that your lawsuit progresses smoothly.
Our product liability attorneys can handle your claim and possess experience in cases similar to yours. Since establishing our firm in 2016, our legal team has successfully resolved personal injury claims amounting to over $300 million.
Contact Van Law Today to Get Started On Your Product Liability Lawsuit
We are committed to ensuring that you receive the financial compensation you deserve. Please don’t hesitate to contact us. Learn about your legal options in a complimentary consultation by phone or engage in a 24/7 chat through our website.
At Van Law Firm, we treat every client’s case with the care it deserves, enabling you to focus on your recovery. Give us a call today and let our experienced attorneys fight on your behalf to earn you the compensation and justice you deserve!
No obligation consultations are always free.
Let Us Help You! Call Now: (725) 900-9000Client Testimonials
Related Videos
